Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.

Eligibility criteria

Qualifiers

Rate current severity of acute/chronic nausea >= 4 on NRS (Numeric Rating Scale)

Diagnosis of cancer

Able to read/write in English

Referred to supportive care service as an inpatient or outpatient

Disqualifiers

Received anti-emetics in the last 30 minutes

Received medical procedures (e.g. blood draws) which required exposure of isopropyl alcohol in the last 30 minutes

Inability to inhale through nares (including recent upper respiratory infection)

Known allergy to isopropyl alcohol

Trial design

Treatments tested in this trial

  • Isopropyl Alcohol
  • Placebo
  • Questionnaire Administration

Treatment groups

112 Participants
are divided into 2 treatment groups

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator